Prenatal diagnosis with cytogenetic analysis has been recognized for more than 20 yr as a safe and reliable method for couples at increased risk of giving birth to a child with a clinically significant chromosomal abnormality [1, 2] . Until Background : Since amniocentesis made prenatal diagnosis feasible in 1967, the method has become a popular tool in obstetric practices. In Korea, the demand for genetic counseling and prenatal tests has increased markedly because the number and proportion of pregnancies in women aged 35 yr and older have increased over a 20-yr period. Here we report clinical and cytogenetic findings on 31,615 mid-trimester amniocenteses.
Background : Since amniocentesis made prenatal diagnosis feasible in 1967, the method has become a popular tool in obstetric practices. In Korea, the demand for genetic counseling and prenatal tests has increased markedly because the number and proportion of pregnancies in women aged 35 yr and older have increased over a 20-yr period. Here we report clinical and cytogenetic findings on 31,615 mid-trimester amniocenteses.
Methods : To investigate the changes in the annual number of amniocentesis, distribution of indications and age, and cytogenetic findings and abnormality rate according to indications, this study retrospectively analyzed 31,615 cases of mid-trimester amniocentesis performed at Seoul Clinical Laboratories, an independent medical laboratory center, during the past 13 yr (1994-2007) .
Results : The annual number of amniocenteses has increased substantially since 1994. Among the 31,615 amniocentesis cases, the maternal age between 30 and 34 yr was the most common age group (35.4%). Among clinical indications, abnormal maternal serum screening results have been the most common indication for amniocentesis since 1994. Chromosomal abnormalities were detected in 973 cases (3.1%). Down syndrome was the most common abnormality found (36.9%, 359/973). In sex chromosomal abnormalities, 53 cases of Turner syndromes, 32 cases of Klinefelter syndromes, 20 cases of triple X syndromes, and 15 cases of 47,XYY were diagnosed. Of structural rearrangements, reciprocal translocations between two autosomes were the most common (15.5%, 151/973). Abnormal ultrasonographic findings showed the highest positive predictive value (5.9%) among the clinical indications.
Conclusions : The present study could be used for the establishment of a database for genetic counseling. The discovery of an abnormality provides the option of termination or continuation in the pregnancy, a more suitable obstetric management in Korea. (Korean J Lab Med 2008; 28:378-85) the early 1990s, amniocentesis was performed on patients at an advanced maternal age and on those with an adverse obstetric history. Nowadays, the importance of amniocentesis has been emphasized due to advances in screening using maternal serum markers and ultrasonography, increased awareness of anomalous children affected by environmental pollution, and increasing maternal age. Rates of chromosomal abnormalities have been estimated in live births [3] , but increasingly, the data collected during amniocentesis have provided estimates for the pregnancy' s second trimester [4, 5] , which can be used in genetic counseling. In Korea, the demand for genetic counseling and pre- New York, USA), 100 U/mL penicillin (Biological, Inc.), and 100 μ g/mL streptomycin (Biological, Inc.) using the technique described elsewhere [6] . Cultures were harvested when colonies were sufficient (at least 15 colonies), 9-15 days (in case of in situ culture method, 6-10 days) after seeding.
MATERIALS AND METHODS

Clinical
Chromosomes were prepared in the usual manner [6] . Routine diagnosis was performed using the GTG-banding technique [7] . In some cases, analysis was completed by the Cbanding technique. 
RESULTS
Annual number of amniocenteses
The number of amniocenteses requested increased substantially after 1994, particularly sharply in 2000 (Fig. 1 ).
Age distribution
Of the 31,615 amniocenteses, 35.4% (11, 192 ) had a maternal age between 30 and 34 yr, which was the most common age group, followed by age 35-39 (30.1%, 9,516), 25-29 (24.1%, 7,619), older than 40 (7.8%, 2,466), 20-24 (2.5%, 790), and 19 yr or younger (0.1%, 32) ( Table 1 ). According to the annual distribution of maternal age groups, the groups aged 30-34 and 35-39 gradually increased, and the groups aged 20-24 and 25-29 decreased, since 1996 (Fig. 2 ).
Clinical indications
The most common clinical indication for amniocentesis was abnormal maternal serum screening results (69.5%), followed by AMA (18.4%), abnormal US findings (5.7%), previous chromosomal abnormalities (1.3%), and previous neonatal death or stillbirth (1.2%) ( Table 2 ). Since 1994, abnormal maternal serum screening results have been the most common indication for amniocentesis, followed by AMA and abnormal US findings (Fig. 3) . According to the distribution of maternal age groups by clinical indications, AMA was the most common indication in ages 35-39, and abnormal maternal serum screening results were the most common indication in ages 30-34, followed by ages 35-39 (data not shown). 20 were parentally inherited and 11 originated de novo.
Cytogenetic findings
Other frequencies by classification for chromosomal abnormalities are shown in Table 3 .
Frequency of chromosomal abnormalities by indications
Of the 1,802 cases with abnormal US findings, 106 resulted in chromosomal abnormalities, which showed the highest positive predictive value (5.9%) among indications, followed by previous chromosomal abnormalities (4.9%), previous congenital anomaly (4.0%), family history of chromosomal abnormalities (3.7%), AMA (3.4%), and abnormal maternal serum screening results (2.8%) ( Table 4) .
DISCUSSION
Since prenatal diagnosis by chromosomal analysis became available using amniocentesis in 1967, it has been increasingly used in obstetric practices for the diagnosis and treatment between 15 and 18 gestational weeks. In the 1980s amniocentesis was used primarily for those in advanced maternal age groups, at least 35 yr old. So far, other recent reports have still shown that prenatal diagnosis of chromosomal disorders has been performed mainly for pregnancies at an advanced maternal age [8, 9] . This study found Sung-Hee Han, Jeong-Wook An, Gyu-Young Jeong, et al.
that abnormal maternal serum screening has been the most common indication for amniocentesis since 1994, followed by advanced maternal age ( Table 2 , Fig. 3 ). This finding was similar to the results of previous studies in Korea [10] [11] [12] [13] [14] [15] . Among the maternal age groups, abnormal maternal serum screening results were the most common indication in patients aged 30 to 34. Maternal serum screening test has been accepted as the prominent indication for amniocenetesis among the obstericians over time. In particular, this test has made remarkable progress as both a routine prenatal screening program and a detection technique in Korea.
In cases with a previous birth that displayed, or a family history of, congenital anomalies or chromosomal abnormalities, there should be a proper diagnosis in consideration of psychiatric stress which could affect the family. This study found 1,012 amniocenteses (3.2%) were requested due to the previous or family history of chromosomal abnormalities or congenital anomalies.
The reports on prenatal diagnosis of amniocentesis, consisting of various numbers of cases, have revealed that the incidence of chromosomal abnormalities ranges between 1.0% and 6.7% [8, [10] [11] [12] [13] [14] [15] [16] [17] . This study found that 3.1% of 31,615 cases had chromosomal abnormalities, which was similar to the data of Karaoguz et al. (3.0%) [8] and Tseng et al.
(2.9%) [9] . A number of cases varies in many studies but, to our knowledge, this study constitutes the largest report in (319 cases), 2.5% (9 cases), and 8.6% (31 cases), respectively.
Of these values, classic Down syndrome showed a lower, and Robertsonian translocation type showed a higher incidence than those seen in previous studies [18] [19] [20] . This find- has slowly increased since 1994, which might be due to an increase in a number of pregnancies in the advanced maternal age group (Fig. 2) , and to a remarkable progress in the maternal serum screening test and ultrasonographic techniques. Of the sex chromosomal abnormalities, Turner syndrome was the most common (0.2%, 53/31,615). Among the 53 Turner syndrome cases, standard monosomy, mosaicism, and structural rearrangement accounted for 34.0% (18 cases), 54.7% (29 cases) and 11.3% (six cases), respectively. Compared to the relative frequencies of Turner syndrome reported by Jacobs et al. [21] and Sybert [22] , standard monosomy and structural rearrangement were found in this study at a lower, and mosaicism at a higher, incidence, which might be due to the possibility of maternal cell contamination and the high sensitivity of detecting mosaicism by the in situ culture method. But other reports have found that mosaicism is common in Turner syndrome, ranging from 66.7% [23] to 90% of cases [24] . The prognosis for mosaic cases is different from pure X monosomy, and the identification of low level mosaicism is crucial for providing accurate prenatal counseling to parents [25] . In this study, some of the mosaic cases showed a second cell line containing two normal X chromosomes (22 cases showed chromosomal abnormalities, the most com- 
